FUSED PYRAZOLE DERIVATIVE HAVING AUTOTAXIN INHIBITORY ACTIVITY

The present invention provides a compound that has an autotaxin inhibitory effect and is represented by formula (I) (in the formula, R1, R2, R3, R4a, R4b, R5a, and R5b are as defined in the description.), a medicine that uses said compound as an active component, and a treatment or prevention method...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: ODAN, MASAHIDE, YAMANE, JUNJI, KOJIMA, HIROTATSU, FUJIKOSHI, CHIAKI, NAGANO, TETSUO, OKABE, TAKAYOSHI, AOKI, JUNKEN, KAWAGUCHI, MITSUYASU, ISHITANI, RYUICHIRO, TATENO, YUSUKE, NISHIMASU, HIROSHI, NUREKI, OSAMU, KATOU, MANABU, TANAKA, NOBUYUKI
Format: Patent
Sprache:eng ; fre ; jpn
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator ODAN, MASAHIDE
YAMANE, JUNJI
KOJIMA, HIROTATSU
FUJIKOSHI, CHIAKI
NAGANO, TETSUO
OKABE, TAKAYOSHI
AOKI, JUNKEN
KAWAGUCHI, MITSUYASU
ISHITANI, RYUICHIRO
TATENO, YUSUKE
NISHIMASU, HIROSHI
NUREKI, OSAMU
KATOU, MANABU
TANAKA, NOBUYUKI
description The present invention provides a compound that has an autotaxin inhibitory effect and is represented by formula (I) (in the formula, R1, R2, R3, R4a, R4b, R5a, and R5b are as defined in the description.), a medicine that uses said compound as an active component, and a treatment or prevention method for a disease involving autotaxin, said treatment or prevention method being characterized by the administration of said compound. La présente invention concerne un composé qui a un effet inhibiteur d'autotaxine et est représenté par la formule (I) (dans la formule, R1, R2, R3, R4a, R4b, R5a, et R5b sont tels que définis dans la description), un médicament qui utilise ledit composé en tant que principe actif, et un procédé de traitement ou de prévention d'une maladie impliquant l'autotaxine, ledit procédé de traitement ou de prévention étant caractérisé par l'administration dudit composé. 本発明は、オートタキシン阻害作用を有する、式(I)(式中、R1、R2、R3、R4a、R4b、R5aおよびR5bは、明細書で定義した通りである。)で示される化合物、該化合物を有効成分とする医薬、および該化合物を投与することを特徴とする、オートタキシンが関与する疾患の治療または予防方法を提供する。
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_WO2015129821A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>WO2015129821A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_WO2015129821A13</originalsourceid><addsrcrecordid>eNrjZLBzCw12dVEIiAxyjPL3cVVwcQ3yDHMM8QxzVfBwDPP0c1dwDA3xD3GM8PRT8PTz8HTyDPEPilRwdAYq8QyJ5GFgTUvMKU7lhdLcDMpuriHOHrqpBfnxqcUFicmpeakl8eH-RgaGpoZGlhZGho6GxsSpAgBEKiub</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>FUSED PYRAZOLE DERIVATIVE HAVING AUTOTAXIN INHIBITORY ACTIVITY</title><source>esp@cenet</source><creator>ODAN, MASAHIDE ; YAMANE, JUNJI ; KOJIMA, HIROTATSU ; FUJIKOSHI, CHIAKI ; NAGANO, TETSUO ; OKABE, TAKAYOSHI ; AOKI, JUNKEN ; KAWAGUCHI, MITSUYASU ; ISHITANI, RYUICHIRO ; TATENO, YUSUKE ; NISHIMASU, HIROSHI ; NUREKI, OSAMU ; KATOU, MANABU ; TANAKA, NOBUYUKI</creator><creatorcontrib>ODAN, MASAHIDE ; YAMANE, JUNJI ; KOJIMA, HIROTATSU ; FUJIKOSHI, CHIAKI ; NAGANO, TETSUO ; OKABE, TAKAYOSHI ; AOKI, JUNKEN ; KAWAGUCHI, MITSUYASU ; ISHITANI, RYUICHIRO ; TATENO, YUSUKE ; NISHIMASU, HIROSHI ; NUREKI, OSAMU ; KATOU, MANABU ; TANAKA, NOBUYUKI</creatorcontrib><description>The present invention provides a compound that has an autotaxin inhibitory effect and is represented by formula (I) (in the formula, R1, R2, R3, R4a, R4b, R5a, and R5b are as defined in the description.), a medicine that uses said compound as an active component, and a treatment or prevention method for a disease involving autotaxin, said treatment or prevention method being characterized by the administration of said compound. La présente invention concerne un composé qui a un effet inhibiteur d'autotaxine et est représenté par la formule (I) (dans la formule, R1, R2, R3, R4a, R4b, R5a, et R5b sont tels que définis dans la description), un médicament qui utilise ledit composé en tant que principe actif, et un procédé de traitement ou de prévention d'une maladie impliquant l'autotaxine, ledit procédé de traitement ou de prévention étant caractérisé par l'administration dudit composé. 本発明は、オートタキシン阻害作用を有する、式(I)(式中、R1、R2、R3、R4a、R4b、R5aおよびR5bは、明細書で定義した通りである。)で示される化合物、該化合物を有効成分とする医薬、および該化合物を投与することを特徴とする、オートタキシンが関与する疾患の治療または予防方法を提供する。</description><language>eng ; fre ; jpn</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2015</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20150903&amp;DB=EPODOC&amp;CC=WO&amp;NR=2015129821A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76289</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20150903&amp;DB=EPODOC&amp;CC=WO&amp;NR=2015129821A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>ODAN, MASAHIDE</creatorcontrib><creatorcontrib>YAMANE, JUNJI</creatorcontrib><creatorcontrib>KOJIMA, HIROTATSU</creatorcontrib><creatorcontrib>FUJIKOSHI, CHIAKI</creatorcontrib><creatorcontrib>NAGANO, TETSUO</creatorcontrib><creatorcontrib>OKABE, TAKAYOSHI</creatorcontrib><creatorcontrib>AOKI, JUNKEN</creatorcontrib><creatorcontrib>KAWAGUCHI, MITSUYASU</creatorcontrib><creatorcontrib>ISHITANI, RYUICHIRO</creatorcontrib><creatorcontrib>TATENO, YUSUKE</creatorcontrib><creatorcontrib>NISHIMASU, HIROSHI</creatorcontrib><creatorcontrib>NUREKI, OSAMU</creatorcontrib><creatorcontrib>KATOU, MANABU</creatorcontrib><creatorcontrib>TANAKA, NOBUYUKI</creatorcontrib><title>FUSED PYRAZOLE DERIVATIVE HAVING AUTOTAXIN INHIBITORY ACTIVITY</title><description>The present invention provides a compound that has an autotaxin inhibitory effect and is represented by formula (I) (in the formula, R1, R2, R3, R4a, R4b, R5a, and R5b are as defined in the description.), a medicine that uses said compound as an active component, and a treatment or prevention method for a disease involving autotaxin, said treatment or prevention method being characterized by the administration of said compound. La présente invention concerne un composé qui a un effet inhibiteur d'autotaxine et est représenté par la formule (I) (dans la formule, R1, R2, R3, R4a, R4b, R5a, et R5b sont tels que définis dans la description), un médicament qui utilise ledit composé en tant que principe actif, et un procédé de traitement ou de prévention d'une maladie impliquant l'autotaxine, ledit procédé de traitement ou de prévention étant caractérisé par l'administration dudit composé. 本発明は、オートタキシン阻害作用を有する、式(I)(式中、R1、R2、R3、R4a、R4b、R5aおよびR5bは、明細書で定義した通りである。)で示される化合物、該化合物を有効成分とする医薬、および該化合物を投与することを特徴とする、オートタキシンが関与する疾患の治療または予防方法を提供する。</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2015</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZLBzCw12dVEIiAxyjPL3cVVwcQ3yDHMM8QxzVfBwDPP0c1dwDA3xD3GM8PRT8PTz8HTyDPEPilRwdAYq8QyJ5GFgTUvMKU7lhdLcDMpuriHOHrqpBfnxqcUFicmpeakl8eH-RgaGpoZGlhZGho6GxsSpAgBEKiub</recordid><startdate>20150903</startdate><enddate>20150903</enddate><creator>ODAN, MASAHIDE</creator><creator>YAMANE, JUNJI</creator><creator>KOJIMA, HIROTATSU</creator><creator>FUJIKOSHI, CHIAKI</creator><creator>NAGANO, TETSUO</creator><creator>OKABE, TAKAYOSHI</creator><creator>AOKI, JUNKEN</creator><creator>KAWAGUCHI, MITSUYASU</creator><creator>ISHITANI, RYUICHIRO</creator><creator>TATENO, YUSUKE</creator><creator>NISHIMASU, HIROSHI</creator><creator>NUREKI, OSAMU</creator><creator>KATOU, MANABU</creator><creator>TANAKA, NOBUYUKI</creator><scope>EVB</scope></search><sort><creationdate>20150903</creationdate><title>FUSED PYRAZOLE DERIVATIVE HAVING AUTOTAXIN INHIBITORY ACTIVITY</title><author>ODAN, MASAHIDE ; YAMANE, JUNJI ; KOJIMA, HIROTATSU ; FUJIKOSHI, CHIAKI ; NAGANO, TETSUO ; OKABE, TAKAYOSHI ; AOKI, JUNKEN ; KAWAGUCHI, MITSUYASU ; ISHITANI, RYUICHIRO ; TATENO, YUSUKE ; NISHIMASU, HIROSHI ; NUREKI, OSAMU ; KATOU, MANABU ; TANAKA, NOBUYUKI</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_WO2015129821A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre ; jpn</language><creationdate>2015</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>ODAN, MASAHIDE</creatorcontrib><creatorcontrib>YAMANE, JUNJI</creatorcontrib><creatorcontrib>KOJIMA, HIROTATSU</creatorcontrib><creatorcontrib>FUJIKOSHI, CHIAKI</creatorcontrib><creatorcontrib>NAGANO, TETSUO</creatorcontrib><creatorcontrib>OKABE, TAKAYOSHI</creatorcontrib><creatorcontrib>AOKI, JUNKEN</creatorcontrib><creatorcontrib>KAWAGUCHI, MITSUYASU</creatorcontrib><creatorcontrib>ISHITANI, RYUICHIRO</creatorcontrib><creatorcontrib>TATENO, YUSUKE</creatorcontrib><creatorcontrib>NISHIMASU, HIROSHI</creatorcontrib><creatorcontrib>NUREKI, OSAMU</creatorcontrib><creatorcontrib>KATOU, MANABU</creatorcontrib><creatorcontrib>TANAKA, NOBUYUKI</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>ODAN, MASAHIDE</au><au>YAMANE, JUNJI</au><au>KOJIMA, HIROTATSU</au><au>FUJIKOSHI, CHIAKI</au><au>NAGANO, TETSUO</au><au>OKABE, TAKAYOSHI</au><au>AOKI, JUNKEN</au><au>KAWAGUCHI, MITSUYASU</au><au>ISHITANI, RYUICHIRO</au><au>TATENO, YUSUKE</au><au>NISHIMASU, HIROSHI</au><au>NUREKI, OSAMU</au><au>KATOU, MANABU</au><au>TANAKA, NOBUYUKI</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>FUSED PYRAZOLE DERIVATIVE HAVING AUTOTAXIN INHIBITORY ACTIVITY</title><date>2015-09-03</date><risdate>2015</risdate><abstract>The present invention provides a compound that has an autotaxin inhibitory effect and is represented by formula (I) (in the formula, R1, R2, R3, R4a, R4b, R5a, and R5b are as defined in the description.), a medicine that uses said compound as an active component, and a treatment or prevention method for a disease involving autotaxin, said treatment or prevention method being characterized by the administration of said compound. La présente invention concerne un composé qui a un effet inhibiteur d'autotaxine et est représenté par la formule (I) (dans la formule, R1, R2, R3, R4a, R4b, R5a, et R5b sont tels que définis dans la description), un médicament qui utilise ledit composé en tant que principe actif, et un procédé de traitement ou de prévention d'une maladie impliquant l'autotaxine, ledit procédé de traitement ou de prévention étant caractérisé par l'administration dudit composé. 本発明は、オートタキシン阻害作用を有する、式(I)(式中、R1、R2、R3、R4a、R4b、R5aおよびR5bは、明細書で定義した通りである。)で示される化合物、該化合物を有効成分とする医薬、および該化合物を投与することを特徴とする、オートタキシンが関与する疾患の治療または予防方法を提供する。</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; fre ; jpn
recordid cdi_epo_espacenet_WO2015129821A1
source esp@cenet
subjects CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title FUSED PYRAZOLE DERIVATIVE HAVING AUTOTAXIN INHIBITORY ACTIVITY
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-13T03%3A08%3A28IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=ODAN,%20MASAHIDE&rft.date=2015-09-03&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EWO2015129821A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true